Hardy Reed LLC Bristol Myers Squibb CO Transaction History
Hardy Reed LLC
- $1.12 Billion
- Q4 2024
A detailed history of Hardy Reed LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hardy Reed LLC holds 6,505 shares of BMY stock, worth $389,974. This represents 0.03% of its overall portfolio holdings.
Number of Shares
6,505
Previous 6,435
1.09%
Holding current value
$389,974
Previous $333,000
10.21%
% of portfolio
0.03%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,604Shares Held
1.47BCall Options Held
31.5MPut Options Held
34.9M-
Vanguard Group Inc Valley Forge, PA189MShares$11.3 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.51 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.57 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.67 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.66 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $127B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...